Human leukemia inhibitory factor upregulates LDL receptors on liver cells and decreases serum cholesterol in the cholesterol-fed rabbit

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 7, 1997, Pages 1267-1273

  Moran, Corey S ^a   Campbell, Julie H ^a   Campbell, Gordon R ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cholesterol; Hepatocytes; LDL; Leukemia inhibitory factor; Rabbits

Indexed keywords

CHOLESTEROL; LEUKEMIA INHIBITORY FACTOR; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; FOAM CELL; HEPATOMA CELL; LIVER CELL; MALE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RABBIT; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER; THORACIC AORTA;

EID: 0030855632     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.7.1267     Document Type: Article

References (30)

1. Tomida M, Yamamoto-Yamaguchi Y, Hozumi M. Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblasts 1929 cells. J Biol Chem. 1984;259:10978-10986.
2. Tomida M. Induction of differentiation of WEHI-3B D+ leukemic cells tranfected with differentiation-stimulating factor/leukemia inhibitory factor receptor cDNA. Blood. 1995;85:217-221.
3. Hilton DJ, Gough NM. Leukemia inhibitory factor: a biological perspective. J Cell Biochem. 1991;46:21-27.
4. Metcalf D. Leukaemia inhibitory factor: a puzzling polyfunctional regulator. Growth Factors. 1992;7:169-173.
5. Steinberg D. Current theories of the pathogenesis of atherosclerosis. In: Steinberg D, Olefsky JM, eds. Hypercholosterolemia and Atherosclerosis - Pathogenesis and Prevention. New York, NY: Churchill/Livingstone; 1987:5.
6. Auwerx J, Marzetta C, Hokanson J. Relationship between hepatic triglyceride lipase and low density lipoprotein characteristics. Arteriosclerosis. 1989;9:319-325.
7. Moran CS, Campbell JH, Simmons DL, Campbell GR. Human leukemia inhibitory factor inhibits development of experimental atherosclerosis. Arterioscler Thromb. 1994;14:1356-1363.
8. Eckel RH. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic disease. N Engl J Med. 1989;320:1060-1065.
9. Mori M, Yamaguchi K, Abe K. Purification of a lipoprotein lipaseinhibiting protein produced by a melanoma cell line associated with cancer cachexia. Biochem Biophys Res Commun. 1989;160:1085-1091.
10. Gearing DP, Nicola NA, Metcalf D, Foote S, Wilson TA, Gough NM, Williams RL. Production of leukemia inhibitory factor (LIF) in Escherichia coli by a novel procedure and its use in maintaining embryonic stem (ES) cells in culture. Biotechnology. 1989;7:1157-1166.
11. Smith DB, Johnson KS. Single-step purification of polypeptides expressed in E. coli as fusions with glutathione S-transferase. Gene. 1988;67:31-42.
12. Samal BB, Arakawa T, Boone TC, et al. High level expression of human leukemia inhibitory factor (LIF) from a synthetic gene in Escherichia coli and the physical and biological characterization of the protein. Biochim Biophys Acta. 1995;1260:27-34.
13. Katterman R, Jaworek D, Möller G, et al. Multicentre study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem. 1984;22:254-261.
14. Campbell JH, Rennick RE, Kalevitch SG, Campbell GR. Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype. Exp Cell Res. 1992;200:156-167.
15. Grove RI, Mazzucco C, Radka SF, et al. Oncostatin M up-regulates low density lipoprotein receptors in HepG2 cells by a novel mechanism. J Biol Chem. 1991;266:18194-18199.
16. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
17. Stary HC, Blankenhorn DH, Chandler AB, Glagor S, Insull W Jr, Richardson M, Rosenfeld ME, Schaffer SA, Schwartz CI, Wagner WD, Wissler RW. A definition of the intima of human arteries and its atherosclerosis-prone regions. Arteriosclerosis. 1992;12:120-127.
18. Ross R. Atherosclerosis: a defense mechanism gone awry. Am J Pathol. 1993;143:987-1002.
19. Auwerx J, Leroy P, Schoonjans K. Lipoprotein lipase: recent contributions from molecular biology. Crit Rev Clin Lab Sci. 1992;29:243-268.
20. Edwards U, Goldberg IJ, Parks JS, Xu H. Lipoprotein lipase enhances the interaction of low density lipoprotein with artery derived extracellular matrix proteoglycans. J Lipid Res. 1993;34:1155-1161.
21. Rennick RE, Campbell JH, Campbell GR. Macrophages enhance binding of beta-VLDL and cholesterol ester accumulation in cultured aortic smooth muscle cells. Heart Vessels. 1994;9:19-29.
22. Bell MC, Carroll GJ. Leukemia inhibitory factor (LIF) suppresses proteoglycan synthesis in porcine and caprine-cartilage explants. Cytokine. 1995;7:137-141.
23. Carroll GJ, Bell MC, Chapman HM, et al. Leukemia inhibitory factor induces leukocyte infiltration and cartilage proteoglycan degradation in goat joints. J Interferon Cytokine Res. 1995;15:567-573.
24. Grove RI, Mazzucco C, Allegretto N, et al. Macrophage-derived factors increase low density lipoprotein uptake and receptor number in cultured human liver cells. J Lipid Res. 1991;32:1889-1897.
25. Liu J, Grove RI, Vestal RE. Oncostatin M activates low density lipoprotein receptor gene transcription in sterol-repressed liver cells. Cell Growth Diff. 1994;5:1333-1338.
26. Sudhoff TC, Goldstein LJ, Brown MS, Russell DW. The LDL receptor gene: a mosaic of exons shared with different proteins. Science. 1985;228:815-822.
27. Lemaire P, Vesque C, Schmitt J, et al. The serum-inducible mouse gene Krox-24 (Erg-1) encodes a sequence-specific transcriptional activator. Mol Cell Biol. 1990;10:3456-3467.
28. Hallahan DE, Sukhatme VP, Sherman ML, et al. Protein kinase C mediates x-ray inducibility of nuclear signal transducers Egr-1 and c-jun. Proc Natl Acad Sci USA. 1991;266:10802-10806.
29. Liu J, Shoyab M, Grove RI. Induction of Egr-1 by oncostatin M precedes up-regulation of low density lipoprotein receptors in HepG2 cells. Cell Growth Diff. 1993;4:611-616.
30. Schiemann WP, Nathanson NM. Involvement of protein kinase C during activation of the mitogen-activated protein kinase cascade by leukaemia inhibitory factor: evidence for participation of multiple signalling pathways. J Biol Chem. 1994;269:6376-6382.